Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Inorganic Biochemistry|November 30, 2024
Effects of structurally varied fluorescent half-sandwich iridium(III) Schiff base complexes on A549 cell lineXicheng Liu, Changjian Ji, Rui Tao, et al.
Dalton Transactions (Cambridge, England : 2003)|December 6, 2023
The anticancer application of half-sandwich iridium(III) ferrocene-thiosemicarbazide Schiff base complexesXicheng Liu, Ao Lv, Pei Zhang, et al.
Journal of Inorganic Biochemistry|May 10, 2024
Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer applicationChangjian Ji, Ruixiao Dong, Pei Zhang, et al.
Journal of Inorganic Biochemistry|November 1, 2024
Anticancer behavior of cyclometallated iridium(III)-tributyltin(IV) carboxylate schiff base complexes with aggregation-induced emissionXicheng Liu, Yiwei Sun, Yuan Gao, et al.
Journal of Inorganic Biochemistry|January 19, 2020
Dual functions of iridium(III) 2-phenylpyridine complexes: Metastasis inhibition and lysosomal damageXicheng Liu, Shujiao Chen, Xingxing Ge, et al.
Dalton Transactions (Cambridge, England : 2003)|June 20, 2020
Triphenylamine/carbazole-modified ruthenium(ii) Schiff base compounds: synthesis, biological activity and organelle targetingShujiao Chen, Xicheng Liu, Jie Huang, et al.
Dalton Transactions (Cambridge, England : 2003)|April 22, 2020
Fluorescent iridium(iii) coumarin-salicylaldehyde Schiff base compounds as lysosome-targeted antitumor agentsCong Liu, Xicheng Liu, Xingxing Ge, et al.
Inorganic Chemistry|September 28, 2019
Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism ResearchXingxing Ge, Shujiao Chen, Xicheng Liu, et al.
Pageof 9